introduction
play

Introduction Many older people presenting to Acute Medical Units are - PowerPoint PPT Presentation

JRF Gladman 1 , JA Edmans 1 , L Bradshaw 1 , SP Conroy 2 1 Division of Rehabilitation and Ageing, University of Nottingham, UK 2 Geriatric Medicine, University Hospitals of Leicester/University of Leicester, UK Simon Conroy: spc3@leicester.ac.uk


  1. JRF Gladman 1 , JA Edmans 1 , L Bradshaw 1 , SP Conroy 2 1 Division of Rehabilitation and Ageing, University of Nottingham, UK 2 Geriatric Medicine, University Hospitals of Leicester/University of Leicester, UK Simon Conroy: spc3@leicester.ac.uk Judi Edmans: judi.edmans@nottingham.ac.uk “This presentation presents independent research commissioned by the National Institute for Health Research (NIHR) under its Programme Grants for Applied Research funding scheme (RP-PG-0407-10147). The views expressed in this presentation are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health.”

  2. Introduction  Many older people presenting to Acute Medical Units are discharged after only a short stay (< 72 hours)  Many re-present to hospital or die within 1 year  Specialist geriatric medical management and short term case management may improve patient outcomes for older patients identified as being at high risk of readmission, functional decline or death  To evaluate the effect of geriatrician input on the outcomes of high risk older people discharged from acute medical assessment units

  3. Methods  Patients aged >/=70, discharged from two UK AMUs  Scoring >/=2 on the Identification of Seniors at Risk tool  Randomised to receive specialist geriatric medical assessment and after care, or usual care  Follow up by postal questionnaire 90 days after randomisation  Outcomes included mortality, institutionalisation, dependency in activities of daily living (ADL), mental well- being, quality of life and falls

  4. Measures  Baseline  Demographics  ISAR score  Health conditions: presenting problems, co-morbidities (Charlson co- morbidity index) and list of medications  Cognitive function: Folstein Mini-Mental State Examination (MMSE)  Personal activities of daily living (ADL): Barthel ADL Index  Health related quality of life/status: EuroQoL EQ5D  Psychological well-being: General Health Questionnaire 12 (GHQ-12)  Follow up  Primary outcome: days at home  Secondary outcomes: mortality, institutionalisation, dependency, mental well-being, quality of life, and health and social care resource use.

  5. Intervention  Assessment prior to discharge by geriatrician  Review of diagnoses and medication review  Further assessment at home or clinic or admission recommended  Advance care planning; liaison with primary care  Intermediate care and specialist community services  Intervention was expected to be complete within one month of randomisation

  6. Enrolment Assessed for eligibility (n=1001) Not included n=568  Excluded n=190  Declined consent n=378 Randomised (n=433) Allocation Allocated to control (n=217) Allocated to intervention (n=216)  Received allocated intervention (n=216)  Received allocated intervention (n=212)  Did not receive allocated intervention (assessed by  Did not receive allocated intervention (not assessed geriatrician) (n=1) by geriatrician) (n=4) Follow-Up  Withdrawn at baseline after initial consent from medical  Withdrawn at baseline after initial consent from practitioner (n=5) medical practitioner (n=11)  Dead at follow-up (n=12)  Dead at follow-up (n=14)  Withdrawn from clinical follow up (n=40)  Withdrawn from clinical follow up (n=34)  Died between follow up date and ascertainment (n=3)  Died between follow up date and ascertainment (n=1) Analysis Analysed for primary outcome and secondary outcomes of Analysed for primary outcome and secondary outcomes mortality, institutionalisation and hospital presentations of mortality, institutionalisation and hospital (n=212) presentations (n=205) Questionnaire for other outcomes completed at 90 days Questionnaire for other outcomes completed at 90 days (n=157) (n=156)  No/incomplete information on GHQ-12 (n=25)  No/incomplete information on GHQ-12 (n=21)  No/incomplete information on EQ5D (n=18)  No/incomplete information on EQ5D (n=10)  No/incomplete information on ICECAP-O (n=37)  No/incomplete information on ICECAP-O (n=25)  No information on falls (n=2)

  7. Results  Groups were well matched for baseline characteristics  Withdrawal rates were similar in both groups (5%)  At 90 days there were no significant differences in:  mean days at home (80.2 days control v 79.7 days intervention)  mortality (6% control v 7% intervention)  proportion moving to care homes (3% both groups)

  8. Results There were no differences in:  Barthel ADL (median: 16, IQR 11 to 19 in each group, n=313)  GHQ 12 (median: control - 12.5, IQR 9 to 18; intervention: 12, IQR 9 to 17 intervention, n=267)  EQ-5D (mean: 0.45, SD 0.32 both groups, n=285)  Proportion of participants who fell at 90 days (43% control v 41% intervention n=311)

  9. Discussion  Comorbidities were not common  Polypharmacy and cognitive impairment were present  Large proportion declined to give consent  Need better method of identifying high risk patients  Isolated specialist geriatric input across the acute – community interface  Need more sophisticated, integrated intervention

  10. Conclusions  Isolated specialist geriatric medical input to high risk patients discharged from AMUs made no difference to measures of:  days at home  dependency in ADL  psychological well-being  quality of life  proportion of participants with a fall during the follow- up period

  11. Baseline measurements

Recommend


More recommend